Camber Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-266,667
| Closed | -$21.6M | – | 46 |
|
2022
Q1 | $21.6M | Buy |
266,667
+16,667
| +7% | +$1.35M | 0.78% | 29 |
|
2021
Q4 | $50.7M | Hold |
250,000
| – | – | 1.74% | 20 |
|
2021
Q3 | $67.4M | Buy |
250,000
+16,667
| +7% | +$4.49M | 2.07% | 21 |
|
2021
Q2 | $60.1M | Buy |
233,333
+100,000
| +75% | +$25.7M | 2.02% | 20 |
|
2021
Q1 | $40M | Sell |
133,333
-33,334
| -20% | -$10M | 1.37% | 23 |
|
2020
Q4 | $42.5M | Hold |
166,667
| – | – | 1.49% | 19 |
|
2020
Q3 | $41.5M | Sell |
166,667
-33,333
| -17% | -$8.29M | 2.19% | 16 |
|
2020
Q2 | $69.5M | Hold |
200,000
| – | – | 3.98% | 9 |
|
2020
Q1 | $53.6M | Sell |
200,000
-50,000
| -20% | -$13.4M | 3.2% | 15 |
|
2019
Q4 | $80.9M | Buy |
250,000
+50,000
| +25% | +$16.2M | 4.12% | 11 |
|
2019
Q3 | $54.6M | Buy |
200,000
+33,333
| +20% | +$9.11M | 2.87% | 15 |
|
2019
Q2 | $89M | Buy |
166,667
+33,334
| +25% | +$17.8M | 4.15% | 6 |
|
2019
Q1 | $67.2M | Hold |
133,333
| – | – | 3.35% | 12 |
|
2018
Q4 | $65.7M | Buy |
133,333
+33,333
| +33% | +$16.4M | 3.12% | 12 |
|
2018
Q3 | $91.4M | Sell |
100,000
-33,333
| -25% | -$30.5M | 3.91% | 8 |
|
2018
Q2 | $97.7M | Buy |
133,333
+33,333
| +33% | +$24.4M | 3.76% | 9 |
|
2018
Q1 | $159M | Sell |
100,000
-123,333
| -55% | -$197M | 7.83% | 2 |
|
2017
Q4 | $200M | Sell |
223,333
-123,334
| -36% | -$110M | 9.79% | 1 |
|
2017
Q3 | $125M | Sell |
346,667
-10,000
| -3% | -$3.6M | 7.91% | 1 |
|
2017
Q2 | $105M | Sell |
356,667
-3,333
| -0.9% | -$977K | 5.09% | 4 |
|
2017
Q1 | $127M | Sell |
360,000
-40,000
| -10% | -$14.1M | 5.14% | 4 |
|
2016
Q4 | $73.6M | Buy |
400,000
+186,667
| +88% | +$34.4M | 3.83% | 7 |
|
2016
Q3 | $55M | Sell |
213,333
-70,000
| -25% | -$18M | 2.42% | 15 |
|
2016
Q2 | $60.5M | Sell |
283,333
-16,667
| -6% | -$3.56M | 2.92% | 13 |
|
2016
Q1 | $61.9M | Buy |
300,000
+66,667
| +29% | +$13.8M | 3.62% | 10 |
|
2015
Q4 | $59M | Buy |
233,333
+83,333
| +56% | +$21.1M | 3.81% | 9 |
|
2015
Q3 | $24.7M | Buy |
150,000
+50,000
| +50% | +$8.22M | 2.11% | 16 |
|
2015
Q2 | $18.8M | Buy |
+100,000
| New | +$18.8M | 1.28% | 22 |
|